Sign in
4

Changes in Ownership

Scinai Immunotherapeutics Ltd. Filed Acc 0001178913-26-003259

Chief Executive Officer acquired 400,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Reichman Amir Chief Executive Officer 2026-06-16 Grant or award +400,000,000 711,637,600 D: show line 1 in the form
Loading xslF345X06/zk2635577.xml…